Today: 15 May 2026
Uranium Energy Corp Stock Slides 6% as New U.S. Uranium Mine Becomes the Real Test
25 April 2026
2 mins read

Uranium Energy Corp Stock Slides 6% as New U.S. Uranium Mine Becomes the Real Test

CORPUS CHRISTI, Texas, April 25, 2026, 12:06 CDT

Uranium Energy Corp. shares dropped roughly 6% on Friday, snapping back as traders reassessed the stock after a sharp run-up tied to U.S. uranium supply developments and the launch of the company’s Burke Hollow mine in South Texas.

The stock’s last trade landed at $14.05. Selling pressure didn’t just hit UEC—shares of Energy Fuels slid 7.2%. Cameco was off 1.4%, with NexGen Energy down 2.5% in U.S. action, marking a broader retreat for uranium names.

Timing counts here: UEC isn’t just pitching potential anymore, it’s stepping into actual production. On April 8, the company announced it had secured a green light from the Texas Commission on Environmental Quality and kicked off output at Burke Hollow—billed as the first new U.S. in-situ recovery uranium project to launch in over ten years. CEO Amir Adnani described the milestone as a “significant achievement,” marking a shift from initial discovery in 2012 to scheduled production in 2026. PR Newswire

Instead of traditional open pit or underground mining, in-situ recovery (ISR) taps wells to dissolve uranium below ground, then pumps the material up for processing. Material from Burke Hollow is set to head for UEC’s Hobson Central Processing Plant, holding a license to process as much as 4 million pounds of uranium annually, according to World Nuclear News.

UEC is pushing for more heft right as U.S. nuclear-fuel security moves from a policy catchphrase to a focus for the market. According to Reuters’ company profile, Uranium Energy supplies uranium for nuclear power and holds U.S. ISR projects, high-grade assets in Canada, plus three hub-and-spoke set-ups across South Texas and Wyoming.

The stock’s recent slide doesn’t undo the gains made operationally. Now, the focus tightens on what’s next—getting wells running, feeding volumes through Hobson, and showing that U.S. output can actually show up on time, sidestepping the setbacks that have dogged nuclear-fuel ventures before.

UEC’s balance sheet—at least on paper—shows some flexibility. Back in March, the company reported selling 200,000 pounds of U3O8, or yellowcake, at $101 per pound. That move brought in $20.2 million in revenue and left $10 million in gross profit. By quarter’s end, liquid assets totaled $818 million, which included $486 million in cash, with zero debt.

UEC isn’t limiting its ambitions to Wyoming or just mining. On March 23, the company announced extraction was underway from three new header houses at Christensen Ranch. Its uranium refining and conversion arm also picked up a docket number from the U.S. Nuclear Regulatory Commission for an upcoming conversion facility. In industry terms, a header house refers to the field unit linking production wells to processing systems.

The ramp isn’t a given. Obstacles like permitting holdups, unpredictable wellfield output, uranium market swings, policy shifts, and execution hiccups at several locations—any of these could stall progress. UEC has flagged risks itself: permitting delays, policy changes, nuclear demand uncertainty, and project funding snags, all could derail its plans.

The stock’s current setup is all about that trade-off. UEC delivers a purer play on U.S. uranium expansion compared with bigger rival Cameco. Energy Fuels and smaller peers are after the same domestic push. But the leverage that lifts these shares in a bull uranium run can cut the other way if traders start doubting the timeline.

At the heart of the argument: nuclear’s place in powering up energy-hungry data centers and similar users. Last year, Reuters flagged that U.S. nuclear-policy orders may give uranium investment a bump. Nick Amicucci at Evercore ISI pointed to a potential pull for more private funds, while Plenisfer Investments’ Marco Mencini called the decision a green light for “renewed contracting and long-term supply confidence.”

UEC faces a straightforward challenge now. Burke Hollow is underway. What investors expect: pounds in the ground, clarity on costs, and no more surprises when it comes to permits.

Stock Market Today

  • Kraken Owner Payward Cuts Jobs as It Prepares for IPO and New Funding
    May 15, 2026, 10:38 AM EDT. Payward, owner of crypto exchange Kraken, has reduced its workforce amid preparations for a potential initial public offering (IPO). The company is also pursuing new funding, aiming for a $20 billion valuation. These moves come as Payward accelerates acquisitions and positions itself for a public market debut, highlighting strategic shifts in the competitive crypto sector.

Latest articles

Plug Power Stock Drops Again: The $5 Billion Hydrogen Turnaround Faces Its Cash Test

Plug Power Stock Drops Again: The $5 Billion Hydrogen Turnaround Faces Its Cash Test

15 May 2026
Plug Power shares fell 1.7% to $3.725 in early Nasdaq trading Friday, following a volatile week after first-quarter results. The company reported a 22% revenue increase to $163.5 million and improved gross margin, but its net loss widened to $245.3 million and operating cash use rose to $150 million. Plug ended March with $802 million in cash and expects $142 million from a hydrogen asset sale in June.
Why Ford Motor Company Stock Is Sliding After Its AI Data Center Rally

Why Ford Motor Company Stock Is Sliding After Its AI Data Center Rally

15 May 2026
Ford shares dropped 7% to $13.43 in early Friday trading, reversing part of a rally sparked by the launch of its new Ford Energy unit. The subsidiary, announced this week, will sell large battery energy storage systems to utilities and data centers, with first deliveries expected in late 2027. CEO Jim Farley said Ford is in the contracting phase with several customers. The stock had surged 13% Wednesday after Morgan Stanley highlighted the business.
Biogen Closes Apellis Deal; APLS Leaves Nasdaq As $5.6 Billion Rare-Disease Bet Begins

Biogen Closes Apellis Deal; APLS Leaves Nasdaq As $5.6 Billion Rare-Disease Bet Begins

15 May 2026
Biogen has closed its acquisition of Apellis Pharmaceuticals, making Apellis a wholly owned subsidiary and delisting its shares from Nasdaq. Apellis shareholders receive $41 per share in cash plus a contingent value right tied to Syfovre sales. Biogen gains the drugs Empaveli and Syfovre, and expands into kidney disease. Biogen borrowed $2 billion to help finance the deal.
Nokia Oyj Stock Pulls Back After AI Rally: What Investors Need to Know

Nokia Oyj Stock Pulls Back After AI Rally: What Investors Need to Know

15 May 2026
Nokia’s U.S.-listed shares dropped about 5% Friday, trading at $13.74 after a recent AI-driven surge. The decline followed a rally sparked by Cisco’s report of $5.3 billion in AI infrastructure orders from hyperscalers. Nokia saw a 54% jump in first-quarter operating profit and named Siemens’ Emma Falck as president of Mobile Infrastructure, effective September 1.
Sirius XM Holdings Inc. Deal Talks With iHeartMedia Could Reshape U.S. Audio Market
Previous Story

Sirius XM Holdings Inc. Deal Talks With iHeartMedia Could Reshape U.S. Audio Market

3M Stock Rises After Profit Beat as Oil Costs Test 2026 Turnaround
Next Story

3M Stock Rises After Profit Beat as Oil Costs Test 2026 Turnaround

Go toTop